Megasys Formulation Development is focused towards improving existing products as well as drug delivery systems and expanding product applications. Qualified scientists work on all facets of pharmaceutical development and technology.

In-house R&D constitutes the backbone of our operations. Substantial investment is made every year; with the main focus on R&D towards the following strategic initiatives:-

Developing new drug formulations for the existing and new drug substances

Improving processes for the existing API and formulation products

Developing new drug delivery systems for the existing and newer active drug substances, as well as new medical devices, mainly in the area of chronic medicine.

Tie-ups with independent research teams to develop new products

Strengthening our intellectual property, including the patenting of new products and drug delivery systems, mainly in the area of respiratory medicine

Conducting clinical and bio-equivalence studies for obtaining regulatory approvals for new products and services

We also leverage our R&D efforts to provide our customers with technical dossiers, plant layouts for pharmaceutical product manufacturing, development of processes and regulatory batches.